|View printer-friendly version|
|Array BioPharma to Present at the Stifel Nicolaus Healthcare Conference and the Rodman & Renshaw Global Investment Conference|
BOULDER, Colo., Aug 29, 2011 (BUSINESS WIRE) --
Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Stifel Nicolaus Healthcare Conference and the Rodman & Renshaw Global Investment Conference. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.arraybiopharma.com&esheet=6843597&lan=en-US&anchor=www.arraybiopharma.com&index=3&md5=cb6bb5876842d864dbda351b4bf0e442.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.